Delafloxacin meglumine
Baxdela is a prescription antibiotic tablet containing delafloxacin meglumine, used to treat certain bacterial infections. It belongs to the fluoroquinolone class and is taken orally. Manufactured by Melinta Therapeutics, LLC. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Baxdela is a prescription antibiotic tablet containing delafloxacin meglumine, used to treat certain bacterial infections. It belongs to the fluoroquinolone class and is taken orally. Manufactured by Melinta Therapeutics, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Delafloxacin meglumine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Delafloxacin meglumine — ANDA 208610 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208610"
}
]
|
| identifier | ANDA208610 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"drug-safety",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Delafloxacin meglumine |
